UPNATURE CEDARWOOD
Natural health product licensed in Canada
- Other names
- Cedarwood
- Licence holder
- Commerce 101 Inc
- NPN or DIN-HM
- 80090453
- Status
- Active licence
- Licence date
- 5 February 2019
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Inhalation, Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Cedrus atlantica Source : Bois | 100 % |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | 1 day |
| Adultes | Not specified | 1 Goutte(s) | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Used in aromatherapy to help relieve colds/cough. Used in aromatherapy as a nervine/calmative. Used in aromatherapy to relieve minor skin irritation/cuts/bruises/burns. Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis. Used in aromatherapy for symptomatic relief of acne/boils.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Do not use essential oils undiluted. Avoid exposure of applied area(s) to the sun. Do not expose the applied area(s) to the sun for 24 to 48 hours after application.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80090453
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.